C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders

Jonathan S C Caudill1, Alexander J Sternberg, Chin-Yang Li

  • 1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Insights

C-terminal nucleophosmin (NPM) mutations are rare in chronic myeloid disorders. However, their presence in chronic myelomonocytic leukaemia (CMML) may indicate an evolving leukaemic clone with poor prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hematology

Background:

  • C-terminal somatic mutations in nucleophosmin (NPM) are associated with acute myeloid leukaemia (AML).
  • NPM is a nucleolar shuttling protein crucial for binding p53 and p19(Arf).

Purpose of the Study:

  • To investigate the prevalence and significance of NPM1 mutations in chronic myeloid disorders.
  • To determine if NPM1 mutations are associated with specific subtypes or clinical outcomes in these disorders.

Main Methods:

  • Analysis of primary marrow samples from 150 patients with various chronic myeloid disorders.
  • Detection of mutations in the NPM1 gene, specifically focusing on the C-terminal region.

Main Results:

  • NPM1 mutations (tetranucleotide duplication) were identified in three patients with chronic myelomonocytic leukaemia (CMML).
  • These patients exhibited a short survival (<1 year) and rapid progression to overt AML.
  • The majority of patients with other chronic myeloid disorders were NPM1-wild type in the analyzed region.

Conclusions:

  • C-terminal NPM mutations are uncommon in the broader spectrum of chronic myeloid neoplasia.
  • The presence of NPM1 mutations in CMML may signify an evolving leukaemic clone with aggressive behavior and poor prognosis.

Related Concept Videos

Mutations01:39

Mutations

Overview
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...